BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3284608)

  • 1. Gonadal regulation of corticotropin-releasing factor immunoreactivity in hypothalamus.
    Haas DA; George SR
    Brain Res Bull; 1988 Mar; 20(3):361-7. PubMed ID: 3284608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic corticotropin-releasing factor immunoreactivity is reduced during induction of pituitary tumors by chronic estrogen treatment.
    Haas DA; Borgundvaag B; Sturtridge WC; George SR
    Life Sci; 1987 Nov; 41(18):2101-6. PubMed ID: 3499556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol or ovariectomy decreases CRF synthesis in hypothalamus.
    Haas DA; George SR
    Brain Res Bull; 1989 Sep; 23(3):215-8. PubMed ID: 2555031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions.
    Haas DA; George SR
    Life Sci; 1987 Dec; 41(25):2725-31. PubMed ID: 2826949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender difference in hypothalamic-pituitary-adrenal axis response to alcohol in the rat: activational role of gonadal steroids.
    Ogilvie KM; Rivier C
    Brain Res; 1997 Aug; 766(1-2):19-28. PubMed ID: 9359583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on hypothalamo-pituitary corticoliberin system. V. The effects of gonadectomy and sex hormones on plasma ACTH and on the reactivity of the anterior pituitary gland to CRF.
    Miśkowiak B; Leśniewska B; Nowak M; Malendowicz LK
    Exp Clin Endocrinol; 1988 Sep; 92(1):1-6. PubMed ID: 2852600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single or repeated mild stress increases synthesis and release of hypothalamic corticotropin-releasing factor.
    Haas DA; George SR
    Brain Res; 1988 Oct; 461(2):230-7. PubMed ID: 2846119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadal steroids regulate rat anterior pituitary levels of TSH-releasing hormone- and pyroglutamyl-glutamyl-proline amide-like immunoreactivity.
    Akinsanya KO; Ghatei MA; Bloom SR
    Endocrinology; 1995 Feb; 136(2):734-40. PubMed ID: 7835305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
    Henry BA; Lightman SL; Lowry CA
    J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal steroid regulation of substance P (SP) and SP-encoding messenger ribonucleic acids in the rat anterior pituitary and hypothalamus.
    Brown ER; Harlan RE; Krause JE
    Endocrinology; 1990 Jan; 126(1):330-40. PubMed ID: 1688409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gonadectomy and reposition of gonadal steroids on alpha-melanocyte-stimulating hormone concentration in discrete hypothalamic areas during a 24-hour period.
    Scimonelli TN; Celis ME
    Neuroendocrinology; 1987 Jun; 45(6):441-5. PubMed ID: 3614548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of beta-endorphin, corticotropin-like intermediate lobe peptide, and alpha-melanotropin-stimulating hormone in the hypothalamus by testosterone.
    Wardlaw SL
    Endocrinology; 1986 Jul; 119(1):19-24. PubMed ID: 3013585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
    Rivest S; Plotsky PM; Rivier C
    Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin releasing factor distribution in normal and Brattleboro rat brain, and effect of deafferentation, hypophysectomy and steroid treatment in normal animals.
    Krieger DT; Liotta A; Brownstein MJ
    Endocrinology; 1977 Jan; 100(1):227-37. PubMed ID: 11988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity.
    Suemaru S; Hashimoto K; Ota Z
    Endocrinol Jpn; 1986 Aug; 33(4):441-8. PubMed ID: 3024953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course study on the effect of reserpine on hypothalamic immunoreactive CRF levels in rats.
    Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
    Brain Res; 1987 Mar; 405(2):247-52. PubMed ID: 3032352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadal regulation of pituitary gonadotropin-releasing hormone receptors during sexual maturation in the rat.
    Duncan JA; Dalkin AC; Barkan A; Regiani S; Marshall JC
    Endocrinology; 1983 Dec; 113(6):2238-46. PubMed ID: 6315346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat.
    Schlussman SD; Zhou Y; Johansson P; Kiuru A; Ho A; Nyberg F; Kreek MJ
    Neurosci Lett; 2000 Apr; 284(3):190-4. PubMed ID: 10773431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen inhibits the increases in hypothalamic corticotropin-releasing hormone (CRH) and CRH-immunoreactivity following gonadectomy.
    Bingaman EW; Magnuson DJ; Gray TS; Handa RJ
    Neuroendocrinology; 1994 Mar; 59(3):228-34. PubMed ID: 8159272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic CRF-like immunoreactivity in the rat after hypophysectomy or adrenalectomy.
    Moldow RL; Fischman AJ
    Peptides; 1982; 3(2):143-7. PubMed ID: 6285319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.